Meiji Yasuda Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History

Meiji Yasuda Asset Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-16,100	Closed	-$199K	–	450
2020 Q2	$199K	Buy	+16,100	New	+$182K	0.02%	458
2020 Q1	–	Sell	-13,500	Closed	-$132K	–	447
2019 Q4	$132K	Hold	13,500	–	–	0.01%	495
2019 Q3	$93K	Hold	13,500	–	–	0.01%	483
2019 Q2	$125K	Sell	13,500 -800	-6%	-$9.65K	0.01%	496
2019 Q1	$224K	Hold	14,300	–	–	0.02%	455
2018 Q4	$221K	Buy	14,300 +100	+0.7%	+$2.05K	0.02%	438
2018 Q3	$306K	Buy	14,200 +1,000	+8%	+$23.2K	0.02%	431
2018 Q2	$321K	Sell	13,200 -800	-6%	-$16.3K	0.03%	423
2018 Q1	$239K	Buy	14,000 +2,200	+19%	+$43K	0.02%	459
2017 Q4	$224K	Sell	11,800 -5,400	-31%	-$81.2K	0.02%	468
2017 Q3	$303K	Hold	17,200	–	–	0.03%	433
2017 Q2	$571K	Sell	17,200 -900	-5%	-$27.9K	0.06%	328
2017 Q1	$581K	Hold	18,100	–	–	0.06%	313
2016 Q4	$656K	Buy	+18,100	New	+$723K	0.07%	281

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

Meiji Yasuda Asset Management's TEVA Position: Q3 2020 in Review

Meiji Yasuda Asset Management sold out of Teva Pharmaceuticals (TEVA) in Q3 2020, closing a stake of 16,100 shares — an estimated $199K sold.

Meiji Yasuda Asset Management first reported a position in TEVA in Q4 2016 and held it in 14 quarters. The position peaked at $656K in Q4 2016. 443 funds tracked by Wall St. Rank hold TEVA as of Q3 2020.

Meiji Yasuda Asset Management reported no remaining Teva Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
Meiji Yasuda Asset Management sold 16,100 Teva Pharmaceuticals shares in Q3 2020, an estimated $199K.
Meiji Yasuda Asset Management first reported a position in Teva Pharmaceuticals in Q4 2016 and held it in 14 quarters.
Meiji Yasuda Asset Management's Teva Pharmaceuticals position peaked at $656K in Q4 2016.
443 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2020.

Based on Meiji Yasuda Asset Management's 13F filing for Q3 2020, filed 12 Nov 2020.